Keyphrases
Acute Myeloid Leukemia
100%
Adult Patients
14%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Annualized Relapse Rate
14%
Antigen Presentation
14%
Class I Alleles
14%
Clinical Covariates
14%
Complete Remission
14%
Confidence Interval
42%
De Novo Acute Myeloid Leukemia
14%
Disease-free Survival
28%
Donor-recipient Matching
42%
Genotype
100%
Hazard Ratio
57%
HLA Alleles
42%
HLA Class I
100%
HLA Haplotypes
28%
Low Risk
14%
Marrow Transplantation
14%
Matched Donors
14%
Multivariable
14%
Non-relapse Mortality
28%
Nucleophosmin 1 (NPM1)
100%
Overall Survival
28%
Peptide Ligand
14%
Relapse Risk
100%
Stronger Binding
57%
Transplant Outcomes
14%
Transplant Recipients
14%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Allele
57%
Allogeneic Hematopoietic Stem Cell Transplantation
42%
Allogeneic Stem Cell Transplantation
100%
Antigen Presentation
14%
Cohort Analysis
14%
Cumulative Incidence
14%
De Novo Acute Myeloid Leukemia
14%
Disease Free Survival
28%
Hazard Ratio
57%
Matched Donor
14%
Nucleophosmin
100%
Overall Survival
28%
Transplantation
28%
Immunology and Microbiology
Allele
100%
Allogeneic Hematopoietic Stem Cell Transplantation
75%
Allogeneic Stem Cell Transplantation
100%
Antigen Presentation
25%
Disease Free Survival
50%
Myeloid
100%
Neoantigen
25%
Overall Survival
50%
Peptides
50%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Cohort Study
14%
De Novo Acute Myeloid Leukemia
14%
Disease Free Survival
28%
Nucleophosmin
100%
Overall Survival
28%
Remission
14%